Title : Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer.

Pub. Date : 2012 Mar

PMID : 22011930






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer. Lapatinib erb-b2 receptor tyrosine kinase 2 Mus musculus
2 PURPOSE: Lapatinib, a small molecule EGFR/HER2 inhibitor, partially inhibits the outgrowth of HER2+ brain metastases in preclinical models and in a subset of CNS lesions in clinical trials of HER2+ breast cancer. Lapatinib erb-b2 receptor tyrosine kinase 2 Mus musculus
3 PURPOSE: Lapatinib, a small molecule EGFR/HER2 inhibitor, partially inhibits the outgrowth of HER2+ brain metastases in preclinical models and in a subset of CNS lesions in clinical trials of HER2+ breast cancer. Lapatinib erb-b2 receptor tyrosine kinase 2 Mus musculus
4 PURPOSE: Lapatinib, a small molecule EGFR/HER2 inhibitor, partially inhibits the outgrowth of HER2+ brain metastases in preclinical models and in a subset of CNS lesions in clinical trials of HER2+ breast cancer. Lapatinib erb-b2 receptor tyrosine kinase 2 Mus musculus